Cardinal Health Inc. appears to be in a strong financial position, buoyed by multiple positive factors. Several banks have bought the company's shares, indicating confidence in their growth. The Board of Directors has further approved an increase in quarterly dividends and the company has successively raised EPS guidance for Fiscal Year 2024. Cardinal Health is achieving positive momentum, with multiple reports identifying it as a strong, long-term value stock. Its pharmaceutical distribution network is set to expand as it acquires Specialty Networks and its PPS Analytics platform. The company has also shown commitment to sustainability, as highlighted in its Fiscal 2023 Environmental, Social and Governance (ESG) Report. The planned dividend increase signals confidence in the company's strong cash flows. Despite losing a contract with UnitedHealth's OptumRX, Cardinal Health has beaten Q3 earning predictions and raised its FY24 view. It has reaffirmed its long-term targets and raised its non-GAAP EPS guidance for 2024.
Cardinal Health CAH News Analytics from Tue, 15 Aug 2023 07:00:00 GMT to Sun, 23 Jun 2024 12:46:24 GMT -
Rating 7
- Innovation 3
- Information 9
- Rumor -1
